Latest Capital Markets News

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

American Rare Earths advances its Halleck Creek Project with record high-grade drilling results, a strategic collaboration with BMO Capital Markets, and a significant state grant, reinforcing its role in securing the U.S. rare earth supply chain.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

OzAurum Resources reports a dynamic quarter with fresh drilling targets at Mulgabbie, high-grade gold at Patricia, and promising niobium anomalies in Brazil, supported by a $1 million capital raise.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

Odessa Minerals has completed key heritage and radiation surveys at its Lyndon Uranium Project and secured $1.1 million in new funding from prominent investors, positioning the company for a focused 2025 exploration campaign.

Pioneer Lithium Limited has lifted its trading suspension following the announcement of a proposed material acquisition and capital raising, signaling a pivotal moment for the company’s growth strategy.

Bellavista Resources has secured nearly A$5 million in capital to fund due diligence on advanced precious and base metal projects, while maintaining a strong cash position and progressing exploration at its Brumby Deposit.

ioneer Ltd’s December 2024 quarterly cash flow report reveals ongoing cash outflows from operations and investing, with nearly $4.5 million spent this quarter but a solid cash reserve providing a runway of almost five quarters.

Saturn Metals has engaged global heap leach engineering leader Kappes Cassiday & Associates to complete the Pre-Feasibility Study for its Apollo Hill Gold Project, marking a pivotal step in advancing the project’s development.

Syrah Resources faced operational setbacks at its Balama graphite mine due to protests, prompting a force majeure declaration, yet it maintains a robust cash position and advances its downstream Vidalia anode material facility amid growing market demand.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.